Back to DNTH
TCG Crossover Management, LLC → DNTH
TCG Crossover Management, LLC DNTH Position History
Dianthus Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$147.6M
Q3 2026
Peak value
$163.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $69.1M |
| Q1 2026 | $140.7M |
| Q2 2026 | $163.4M |
| Q3 2026 | $147.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $147.6M | 1.68M | — | — |
| Q2 2026 | $163.4M | 1.68M | — | — |
| Q1 2026 | $140.7M | 1.68M | — | — |
| Q4 2025 | $69.1M | 1.68M | — | — |
Other funds holding DNTH
$572.9M
$523.1M
$469.1M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC